Conjupri is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cspc Ouyi Pharmaceutical Co. Ltd. The primary component is Levamlodipine Maleate.
Product ID | 24075-0410_67f32327-7a9f-49bf-82dc-c3246151886a |
NDC | 24075-0410 |
Product Type | Human Prescription Drug |
Proprietary Name | Conjupri |
Generic Name | Levamlodipine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2020-12-19 |
Marketing Category | NDA / NDA |
Application Number | NDA212895 |
Labeler Name | CSPC Ouyi Pharmaceutical Co. Ltd |
Substance Name | LEVAMLODIPINE MALEATE |
Active Ingredient Strength | 1 mg/1.25mg |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2020-12-19 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
24075-0410 | Conjupri | levamlodipine |
24075-0411 | Conjupri | levamlodipine |
24075-0412 | Conjupri | levamlodipine |
24075-0413 | Conjupri | levamlodipine |
66992-425 | Conjupri | levamlodipine |
66992-430 | Conjupri | levamlodipine |
69101-512 | Conjupri | levamlodipine maleate |
69101-525 | Conjupri | levamlodipine maleate |
69101-550 | Conjupri | levamlodipine maleate |
42195-425 | Levamlodipine | levamlodipine |
42195-450 | Levamlodipine | levamlodipine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CONJUPRI 88716966 not registered Live/Pending |
Conjupro Biotherapeutics Inc. 2019-12-05 |